National Perinatal Epidemiology and Statistics Unit, School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia.
National Perinatal Epidemiology and Statistics Unit, School of Women's and Children's Health, University of New South Wales, Sydney, New South Wales, Australia.
Fertil Steril. 2014 Jan;101(1):191-198.e4. doi: 10.1016/j.fertnstert.2013.09.005. Epub 2013 Oct 21.
To systematically quantify the impact of consumer cost on assisted reproduction technology (ART) utilization and numbers of embryos transferred.
Ordinary least squared (OLS) regression models were constructed to measure the independent impact of ART affordability-measured as consumer cost relative to average disposable income-on ART utilization and embryo transfer practices.
Not applicable.
PATIENT(S): Women undergoing ART treatment.
INTERVENTION(S): None.
MAIN OUTCOME MEASURE(S): OLS regression coefficient for ART affordability, which estimates the independent effect of consumer cost relative to income on utilization and number of embryos transferred.
RESULT(S): ART affordability was independently and positively associated with ART utilization with a mean OLS coefficient of 0.032. This indicates that, on average, a decrease in the cost of a cycle of 1 percentage point of disposable income predicts a 3.2% increase in utilization. ART affordability was independently and negatively associated with the number of embryos transferred, indicating that a decrease in the cost of a cycle of 10 percentage points of disposable income predicts a 5.1% increase in single-embryo transfer cycles.
CONCLUSION(S): The relative cost that consumers pay for ART treatment predicts the level of access and number of embryos transferred. Policies that affect ART funding should be informed by these findings to ensure equitable access to treatment and clinically responsible embryo transfer practices.
系统评估消费者成本对辅助生殖技术（ART）应用和胚胎移植数量的影响。
构建普通最小二乘法（OLS）回归模型，以衡量 ART 可负担性（以消费者成本相对于平均可支配收入来衡量）对 ART 应用和胚胎移植实践的独立影响。
不适用。
接受 ART 治疗的女性。
无。
ART 可负担性的 OLS 回归系数，该系数估计了消费者成本相对于收入对应用和胚胎移植数量的独立影响。
ART 可负担性与 ART 应用呈独立正相关，平均 OLS 系数为 0.032。这表明，平均而言，可支配收入中每降低 1 个百分点的周期成本预计会使应用率增加 3.2%。ART 可负担性与胚胎移植数量呈独立负相关，表明可支配收入中每降低 10 个百分点的周期成本预计会使单胚胎移植周期增加 5.1%。
消费者为 ART 治疗支付的相对成本预测了治疗的可及性和胚胎移植数量。影响 ART 资金的政策应考虑到这些发现，以确保公平获得治疗和符合临床责任的胚胎移植实践。
